Probi to acquire Nutraceutix

10 Jun 2016

Swedish probiotics company Probi has announced that its US subsidiary has signed an asset purchase agreement under which Probi will acquire the operations of the US probiotic company Nutraceutix for $105 million.

Probi to acquire Nutraceutix

Swedish probiotics company Probi has announced that its US subsidiary has signed an asset purchase agreement under which Probi will acquire the operations of the US probiotic company Nutraceutix for a preliminary cash purchase price of $105 million.

With this Acquisition, Probi says it will increase its market share in North America more than three-fold, add important new technologies, manufacturing capabilities and customers, and create a strong platform for further acquisitions.

According to Probi, the transaction makes it a top tier integrated probiotics player with dramatically enhanced scale, geographic footprint, capability base and value chain presence, and will more than double Probi¡¦s current size;

The acquisition is said to combine proven, proprietary and patented delivery technology from Nutraceutix with Probi’s well documented strain portfolio, enabling novel, differentiated probiotics products, and to secure access to established, GMP-compliant and versatile manufacturing capabilities with important strategic and financial benefits.